Glitter-M may be available in the countries listed below.
Metformin is reported as an ingredient of Glitter-M in the following countries:
Pioglitazone is reported as an ingredient of Glitter-M in the following countries:
International Drug Name Search
Generic Name: buprenorphine (transdermal) (BUE pre NOR feen)
Brand Names: Butrans
Buprenorphine is a narcotic (opioid) pain medicine.
Buprenorphine transdermal (skin patch) is used to treat moderate to severe chronic pain when treatment is needed around the clock.
Buprenorphine transdermal may also be used for purposes not listed in this medication guide.
Never wear more than 1 buprenorphine skin patch at a time unless your doctor has told you to.
Call your doctor at once if you have weak or shallow breathing, snoring that is new or unusual, slow heart rate, confusion, severe dizziness, seizure, or feeling like you might pass out.
asthma or severe breathing disorder; or
a bowel obstruction called paralytic ileus.
To make sure you can safely use buprenorphine, tell your doctor if you have any of these other conditions:
COPD (chronic obstructive pulmonary disease), sleep apnea, or other breathing disorders;
a personal or family history of "Long QT syndrome":
hepatitis B or C;
liver or kidney disease;
a thyroid disorder;
gallbladder disease;
curvature of the spine;
a history of head injury or brain tumor;
epilepsy or other seizure disorder;
low blood pressure;
Addison's disease or other adrenal gland disorders;
enlarged prostate, urination problems;
depression or other mental illness; or
a history of drug or alcohol addiction.
Your dose needs may be different if you have recently used an opioid pain medicine and your body is tolerant to it. Opioids include Tylenol #3, Lortab, Vicodin, OxyContin, Percocet, Darvocet, Actiq, morphine, and many others. Talk with your doctor if you are not sure you are opioid-tolerant.
Use exactly as prescribed. Never use buprenorphine in larger amounts, or for longer than recommended by your doctor. Follow the directions on your prescription label. Tell your doctor if the medicine seems to stop working as well in relieving your pain.
This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.
If you are switching to buprenorphine transdermal from another narcotic pain medicine, you may need to slowly stop using the other medicine. Follow your doctor's instructions.
Apply the skin patch only to clean, dry skin. Use only clear water to wash the skin before you apply a skin patch. Soaps or other chemicals could increase the amount of buprenorphine your skin absorbs.
Apply the patch to a flat and hairless area of the chest, back, side, or outer side of your upper arm. Wear the patch around the clock for 7 days. Never wear more than 1 buprenorphine skin patch at a time unless your doctor has told you to.
Do not use a buprenorphine transdermal skin patch if it has been cut or damaged.
After removing a skin patch fold it in half, sticky side in, and flush the patch down the toilet or use the Patch-Disposal Unit provided with this medication. Apply a new patch to a different skin area on the chest, back, side, or upper arm. Do not use the same skin area twice in a row.
Keep track of how many skin patches have been used from each new package of this medicine. Buprenorphine is a drug of abuse and you should be aware if any person in the household is using this medicine improperly or without a prescription.
If you forget to change a patch on your scheduled day, remove the patch and apply a new one as soon as you remember. Do not wear extra patches to make up a missed dose.
Overdose symptoms may include extreme drowsiness, weak or limp feeling, weak pulse, cold and clammy skin, fainting, shallow breathing, snoring, or breathing that stops.
slow heart rate, weak or shallow breathing, deep sighs, snoring that is new or unusual;
confusion, severe dizziness, feeling like you might pass out;
blisters, swelling, or severe irritation where the patch was worn;
seizure (convulsions); or
nausea, upper stomach pain, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).
Less serious side effects may include:
headache;
vomiting, dry mouth, upset stomach, constipation;
mild dizziness or drowsiness; or
redness, itching, or mild skin rash where the patch was worn.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
dexamethasone (Decadron, Hexadrol);
St. John's wort;
rifabutin (Mycobutin), rifampin (Rifadin, Rifater, Rifamate), or rifapentine (Priftin);
phenobarbital (Solfoton) or other barbiturates;
diazepam (Valium) or similar medicines such as alprazolam (Xanax), lorazepam (Ativan), clorazepate (Tranxene), and others;
a heart rhythm medication such as amiodarone (Cordarone, Pacerone), disopyramide (Norpace), dofetilide (Tikosyn), flecaininde (Tambocor), procainamide (Pronestyl), propafenone, (Rythmol), quinidine (Quin-G), sotalol (Betapace), and others;
HIV medication such as efavirenz (Sustiva), etravirine (Intelence), nevirapine (Viramune), or ritonavir (Kaletra, Norvir); or
seizure medication such as carbamazepine (Carbatrol, Tegretol), felbamate (Felbatol), oxcarbazepine (Trileptal), phenytoin (Dilantin), or primidone (Mysoline).
This list is not complete and other drugs may interact with buprenorphine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: Butrans side effects (in more detail)
Rilace plus may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Rilace plus in the following countries:
Lisinopril is reported as an ingredient of Rilace plus in the following countries:
International Drug Name Search
Ciza-MPS may be available in the countries listed below.
Cisapride monohydrate (a derivative of Cisapride) is reported as an ingredient of Ciza-MPS in the following countries:
Dimeticone is reported as an ingredient of Ciza-MPS in the following countries:
International Drug Name Search
Lamotrigine Generics may be available in the countries listed below.
Lamotrigine is reported as an ingredient of Lamotrigine Generics in the following countries:
International Drug Name Search
Detrunorm may be available in the countries listed below.
UK matches:
Propiverine hydrochloride (a derivative of Propiverine) is reported as an ingredient of Detrunorm in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Generic Name: ribavirin (oral) (rye ba VYE rin)
Brand Names: Copegus, Rebetol, RibaPak, Ribasphere, RibaTab
Ribavirin is an antiviral medication.
Ribavirin must be used together with an interferon alfa product (such as Pegasys, PegIntron, Sylatron, or Intron A) to treat chronic hepatitis C.
Ribavirin may also be used for purposes not listed in this medication guide.
Use at least two effective forms of birth control while either sexual partner is taking ribavirin, and for at least 6 months after treatment ends. Tell your doctor right away if a pregnancy occurs while either the mother or the father is taking ribavirin.
severe liver disease (especially cirrhosis);
autoimmune hepatitis;
a hemoglobin disorder such as anemia, thalassemia (Mediterranean anemia), or sickle-cell anemia;
if you are also taking didanosine (Videx); or
if you are pregnant woman, or a man whose female sexual partner is pregnant.
To make sure you can safely take ribavirin, tell your doctor if you have any of these other conditions:
hepatitis B infection;
a blood cell disorder such as hemolytic anemia (a lack of red blood cells);
human immunodeficiency virus (HIV or AIDS);
diabetes;
a pancreas disorder;
sarcoidosis;
breathing problems;
a thyroid disorder;
new or worsening eye problems (such as retinopathy);
a history of heart disease, high blood pressure, or a heart attack;
a history of depression or suicide attempt;
a history of a liver, kidney, or other organ transplant; or
if you have ever received treatment for hepatitis C that did not work well.
If you are a woman, do not take ribavirin if you are pregnant. You will need frequent pregnancy tests to make sure you are not pregnant while taking ribavirin.
If you are a man, do not take ribavirin if your female sexual partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin. Your sexual partner will need frequent pregnancy tests to make sure she is not pregnant while you are taking ribavirin.
Use at least two effective forms of birth control while either sexual partner is taking ribavirin, and for at least 6 months after treatment ends.
Tell your doctor right away if a pregnancy occurs while either the mother or the father is taking ribavirin.
Your name may need to be listed on a ribavirin pregnancy registry if you become pregnant while you or your male sexual partner are taking this medication or during the 6 months after treatment ends. This is to track the outcome of the pregnancy and to evaluate any effects of ribavirin on the baby.
Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
Measure the liquid form of ribavirin with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.
Use ribavirin regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.
Drink extra fluids while you are taking ribavirin to keep from getting dehydrated, especially during exercise or in hot weather.
Ribavirin can cause dry mouth, which could lead to tooth decay or gum disease. If you vomit while taking ribavirin, rinse your mouth out with water to prevent damage to your teeth or gums. Be sure to have regular dental exams while you are taking this medication.
Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. If you have not taken the medication for longer than 24 hours, call your doctor for instructions. Do not take extra medicine to make up the missed dose.
Treatment with ribavirin does not prevent spread of the hepatitis C virus to other people. Follow your doctor's instructions about how to prevent passing the disease to another person.
problems with your vision;
fever, chills, body aches, flu symptoms;
severe pain in your upper stomach spreading to your back, nausea and vomiting, fast heart rate;
stabbing chest pain, wheezing, feeling short of breath;
severe depression, hallucinations, thoughts of suicide or hurting yourself;
chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling; or
pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness.
Less serious side effects may include:
headache;
muscle pain;
dry mouth;
nausea; vomiting, stomach pain, loss of appetite;
weight loss;
feeling tired or irritable;
anxiety, mood changes; or
pain, swelling, or irritation where the interferon injection was given.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Tell your doctor about all other medicines you use, especially:
abacavir (Ziagen);
azathiopriine (Azasan, Imuran);
lamivudine (Combivir, Epivir, Epzicom, Trizivir);
stavudine (Zerit);
tenofovir (Viread);
zalcitabine (Hivid); or
zidovudine (Retrovir, AZT).
This list is not complete and other drugs may interact with ribavirin. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: Ribasphere side effects (in more detail)
Remoxicam may be available in the countries listed below.
Piroxicam is reported as an ingredient of Remoxicam in the following countries:
International Drug Name Search
Pulvex Spot may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Permethrin is reported as an ingredient of Pulvex Spot in the following countries:
International Drug Name Search
Lansoprazol Apotex may be available in the countries listed below.
Lansoprazole is reported as an ingredient of Lansoprazol Apotex in the following countries:
International Drug Name Search
Redulip may be available in the countries listed below.
Simvastatin is reported as an ingredient of Redulip in the following countries:
International Drug Name Search
Azithral may be available in the countries listed below.
Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Azithral in the following countries:
International Drug Name Search
The following drugs and medications are in some way related to, or used in the treatment of Clostridial Infection. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
See sub-topics
Aeroflux may be available in the countries listed below.
Ambroxol is reported as an ingredient of Aeroflux in the following countries:
Salbutamol is reported as an ingredient of Aeroflux in the following countries:
Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Aeroflux in the following countries:
International Drug Name Search
Quinine Ethylcarbonate may be available in the countries listed below.
Quinine Ethylcarbonate (JAN) is known as Quinine in the US.
International Drug Name Search
Glossary
| JAN | Japanese Accepted Name |
Rino Calyptol may be available in the countries listed below.
Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Rino Calyptol in the following countries:
International Drug Name Search
In the US, Hydergine (ergoloid mesylates systemic) is a member of the drug class miscellaneous central nervous system agents and is used to treat Alzheimer's Disease, Arteriosclerotic Dementia and Dementia.
US matches:
Dihydroergocristine mesilate (a derivative of Dihydroergocristine) is reported as an ingredient of Hydergine in the following countries:
Dihydroergotoxine is reported as an ingredient of Hydergine in the following countries:
Dihydroergotoxine mesilate (a derivative of Dihydroergotoxine) is reported as an ingredient of Hydergine in the following countries:
International Drug Name Search
Elcofar may be available in the countries listed below.
Omeprazole is reported as an ingredient of Elcofar in the following countries:
International Drug Name Search
